The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candi
about
Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and FerritinType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVNAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.Alcohol and Steatosis: The Japanese ParadoxRegulatory landscape of AGE-RAGE-oxidative stress axis and its modulation by PPARγ activation in high fructose diet-induced metabolic syndrome.FOXO transcription factors protect against the diet-induced fatty liver disease.Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.Effects of canagliflozin, an SGLT2 inhibitor, on hepatic function in Japanese patients with type 2 diabetes mellitus: pooled and subgroup analyses of clinical trials.Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population.NAFLD: Is There Anything New under the Sun?Nonalcoholic fatty liver disease: Evolving paradigms.Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.Clinical relevance of liver histopathology and different histological classifications of NASH in adults.Pioglitazone suppresses inflammation and fibrosis in nonalcoholic fatty liver disease by down-regulating PDGF and TIMP-2: Evidence from in vitro study.The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: A 7-year prospective study.Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients.Letter: is HIV infection an important factor for liver fibrosis?Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment.Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease.Drug-induced steatohepatitisCurrent status of imaging in nonalcoholic fatty liver disease
P2860
Q26750865-1A6B1903-1CC7-428A-8071-7B8FCBF6D770Q26752583-B955D53B-E1E5-472F-B0C6-B7EA37535637Q28079826-D49DB84C-31E6-42A3-81FC-0A0F15F7E574Q33844463-3524AD2F-F46B-468D-BDC3-917CCB937600Q36325487-7C9C7A68-5259-49B4-B18A-5D6D1FF5BC17Q37034826-9A8DFAF4-B9D0-49C1-99C3-577496C23DFAQ37586657-9BA37F42-BCD9-4F7C-AEF1-03E37FF5A61CQ37704641-C8D3481D-D0E6-4F27-9994-0534E149299FQ38642356-8E9945C0-FEBD-4A31-A08E-32F62FE3E464Q38698155-5DD2EF8D-0948-4554-8D51-0485F3A80486Q39021862-01102B43-4642-4680-ACC7-D75A38B21166Q42365416-8269678C-83C9-44EC-8584-915A39E52A58Q42365749-FAA3382B-10B1-4D91-A769-5D31BA63EE9DQ42695154-4523072D-A0C6-47C1-93A6-EAD3D8141A2FQ45067817-231F4DA6-86B3-488F-BEFA-7B185677ACCCQ47581786-1E187BFD-2D78-49A9-BF99-08ADB26D80B8Q47746064-FBB0A32A-CFE6-48F9-A59F-DE24A0B3530BQ47884913-21E8C4AC-C13E-4D01-9F5E-3A5D577284ABQ48196520-1ADCF6EF-864C-46C6-A183-6E59937EB7AFQ48329929-260F04DD-6CE6-4A73-8ECB-6F5537A3C6F1Q48353282-B3A88F26-E87B-4036-9E48-09824A6ED464Q50059733-AAE4DEF2-83DE-4D1B-B255-1551B894D7F1Q52960139-8844056E-195D-4645-B752-E508F44C0456Q54514631-FF10361F-DD6E-4B38-A0CC-5BF8F1EB3BBFQ55323878-23998B89-777F-4A54-A968-311D7CF0A581Q55462318-551FBB37-EDAD-4442-B75D-AF24644A3436Q56541717-45D0CD2D-8C70-4631-81CF-EEA3B7C13735Q58700636-9DF1A267-4FB4-4DD8-92D3-9157D94725D9
P2860
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candi
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The independent predictors of ...... clue to pathogenesis and candi
@en
type
label
The independent predictors of ...... clue to pathogenesis and candi
@en
prefLabel
The independent predictors of ...... clue to pathogenesis and candi
@en
P2860
P50
P356
P1433
P1476
The independent predictors of ...... andidate targets for treatment
@en
P2093
Dante Romagnoli
P2860
P304
P356
10.1111/HEPR.12656
P577
2016-03-30T00:00:00Z